Spindletop Capital

Address: 110 Stone Oak Pkwy, San Antonio TX 78258 Main Phone: 210-268-0129 Business Email: paindoc@sapaindoc.com Business Website: http://www.sapaindoc.com Interventional Pain Management under the guidance of Dr. Urfan Dar offers a unique approach to avoid chronic pain to maintain quality of life. Helping people alleviate back and neck pain in San Antonio and New Braunfels we are the best pain management doctors and specialists in the area. Call us today for a consultation. Services: Pain Management, Minimally Invasive Laser Spine Surgery Hours: Mon to Fri 8:00 AM to 5:00 PM , Sat & Sun : Closed Payment Methods: amex, debit, mc, discover, visa

Castle Biosciences, Inc. is a commercial-stage biotechnology company focused on developing and commercializing diagnostic and prognostic tests for dermatological cancers. The company's lead product, DecisionDx-Melanoma, is a multi-gene expression profile test designed to identify stage I and II melanoma patients at high risk of metastasis by analyzing biological information from 31 genes in tumor tissue. In addition, Castle Biosciences offers the DecisionDx-UM test, which predicts metastasis risk in uveal melanoma patients, and is developing two late-stage products targeting cutaneous squamous cell carcinoma and suspicious pigmented lesions. The company's tests provide personalized, clinically actionable genomic information to assist physicians and patients in making informed treatment decisions. Founded in 2007 and headquartered in Friendswood, Texas, Castle Biosciences aims to significantly impact cancer diagnosis and management through its innovative diagnostic solutions.

HNI Healthcare (formerly Hospitalists Now) is a technology-enabled physician practice management company focused on the delivery of full-service facility-based physician programs to improve the quality of patient care. The Company’s physicians, processes and technologies enable healthcare facilities to improve key quality and performance metrics through a more clinically integrated care model.

QSpex Technologies, Inc. is an optical service center based in Alpharetta, Georgia, that specializes in producing high-quality finished eyewear in the United States. Founded in 2007, the company developed a patented method for manufacturing premium lenses directly in optical offices, allowing for a cost-effective and efficient process. Utilizing advanced touchless transfer technology, QSpex enables the quick fabrication of lenses, including single vision, progressive, anti-reflective, photochromic, and polar options, with lens treatments integrated during the production process. This innovative approach allows eyewear providers to deliver finished products to patients on the same day as their eye exams. However, the company filed for voluntary liquidation under Chapter 7 in June 2020.

QSpex Technologies, Inc. is an optical service center based in Alpharetta, Georgia, that specializes in producing high-quality finished eyewear in the United States. Founded in 2007, the company developed a patented method for manufacturing premium lenses directly in optical offices, allowing for a cost-effective and efficient process. Utilizing advanced touchless transfer technology, QSpex enables the quick fabrication of lenses, including single vision, progressive, anti-reflective, photochromic, and polar options, with lens treatments integrated during the production process. This innovative approach allows eyewear providers to deliver finished products to patients on the same day as their eye exams. However, the company filed for voluntary liquidation under Chapter 7 in June 2020.